Collectively the risk alleles identified herein map to genes known to be regulatory for B-cell development and the control of autoimmunity supporting the concept that either aberrant BCR signals and/or a breakdown in normal immunological tolerance contributes to CLL clonal expansion and the subsequent acquisition of somatic driver mutations. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.